Journal of virus eradication
OP 1.1 Expression profiling of HIV latently-infected cells using nanostring and mass cytometry.
OP 4.2 Characterising ‘exceptional’ control among HIV elite controllers.
12 In-depth transcription profile comparison of multiple primary cell HIV latency models.
10 Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood.
20 Kansui, an ingenol-containing herbal supplement, safely induced CD8, NK, and monocyte activation in three ART-suppressed SIVmac251-infected rhesus macaques.
PP4.10 HIV integrates in genes regulating cell cycle, DNA damage, and viral transport.
PP5.3 TCF-1 expression is associated with HIV-specific CD8+ T cell proliferative capacity.
OA2-3 Small-molecule chemotherapeutic drugs reactivate HIV-1 via non-canonical pathways and modulate CD8 T cell response.
Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies.
PP 3.19 Evidence of ongoing HIV replication during suppressive antiretroviral therapy.
